scispace - formally typeset
T

Takeo Kawashiro

Researcher at Keio University

Publications -  63
Citations -  579

Takeo Kawashiro is an academic researcher from Keio University. The author has contributed to research in topics: Lung injury & Tuberculosis. The author has an hindex of 11, co-authored 63 publications receiving 564 citations. Previous affiliations of Takeo Kawashiro include Kyoto University.

Papers
More filters
Journal ArticleDOI

Soluble form of P-selectin in plasma is elevated in acute lung injury.

TL;DR: The soluble form of P-selectin in plasma was measured from 19 patients (surviving, 11; deceased, 8) with ALI due to various causes and the clinical significance of this measurement was assessed.
Journal ArticleDOI

Arterial blood gases in undisturbed resting birds: measurements in chicken and duck

TL;DR: Arterial blood was sampled in resting, unrestrained and undisturbed birds using a remote-controlled sampling device for analysis of PO2, PCO2 and pH at the body temperature of the animal.
Journal ArticleDOI

Elevated levels of interleukin-8 and leukotriene B4 in pulmonary edema fluid of a patient with reexpansion pulmonary edema

TL;DR: In this case, protein leakage and polymorphonuclear leukocyte (PMN) accumulation were observed in the reexpanded lung and plasma level of P-selectin, which mediates adhesion between PMN and endothelium, was elevated.
Journal ArticleDOI

Long-Term Course of Bronchiectasis and Bronchiolitis obliterans as Late Complication of Smoke Inhalation

TL;DR: It is believed that symptoms and physiological derangement were due mainly to bronchiolitis obliterans, and that once the pathophysiological condition had been established following the initial injury, it could be maintained by conservative medical management.
Journal Article

Priming of alveolar macrophages for interleukin-8 production in patients with idiopathic pulmonary fibrosis

TL;DR: In this article, the authors evaluated the contribution of interleukin-8 (IL-8) to the pathogenesis of idiopathic pulmonary fibrosis (IPF) by studying bronchoalveolar lavage fluid (BALF) in eight patients with IPF in the chronically progressive phase, five patients with pneumonia in the subacutely progressive phase and eight patients suffering from sarcoidosis (SAR), and eight control (CTL) subjects.